Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Facts about Cognizant

Facts about Cognizant

posted on Dec 08, 2009 10:39AM

History

Founded in 1994 as a captive arm of Dun & Bradstreet

Traded on NASDAQ since 1998

Stock symbol: NASDAQ: CTSH

Member since 2004: NASDAQ-100 Index

Member since 2006: S&P 500 Index

Financials

Fiscal Year ’09 ends December 31, 2009

Estimated Revenues for 2009: $3.255 billion

2008 Revenues: $2.816 billion

Diluted EPS ’08 (GAAP): $1.44

Net Income ’08 (GAAP): $430.8 million

Operating margin ’08 (GAAP): 18.3%

Revenue Mix

North America: 78.3%, Europe: 19.2%, Asia: 2.5%

Financial Services: 42.7%, Healthcare: 26.5%,

Retail/Manufacturing & Logistics: 17.2%,

Communications, Information, Media & Entertainment,

Technology: 13.6%

Share
New Message
Please login to post a reply